{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:02:14Z","timestamp":1787169734497,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>To assess the change of interleukin-6 (IL-6) levels in tears and ocular clinical parameters in corneal ulcer patients with moderate-to-severe infection after adjunctive therapy with platelet-rich fibrin (PRF) lysate-eyedrops compared with autologous serum eyedrops.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>This study was a randomized double-blind controlled trial, which compared two groups of patients at Dr. Sardjito Hospital, Yogyakarta. A total of 42 patients (42 eyes) were divided into the control group (21 patients) and the intervention group (21 patients). All patients received antibacterial\/antifungal therapy based on the etiology, and an adjunctive eyedrop therapy: autologous serum eyedrops for the control group and PRF lysate eyedrops for the intervention group. The IL-6 levels and clinical changes in patients, such as the area of corneal defects, pericorneal injection, and the level of blepharospasm were measured at the baseline, day 6, and day 13 after starting the treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Compared to baseline, the mean IL-6 level in day 13 decreased by 426.6 \u00b1 665.4 pg\/ml (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005) and 1283.7 \u00b1 1569.1 pg\/ml (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.079) in the intervention and control groups, respectively. However, the difference between the two groups was not statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.164). In term of corneal defect area, there was a significant decrease at day 6 and day 13 in both groups but there was no statistically significant difference between the two groups in all time points. Similarly, the proportion of blepharospasm and pericorneal injection severity appeared to improve especially on day 13 in both groups but were not statistically different between the two.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>There was a statistically significant decrease in IL-6 levels in the tears in patient using PRF lysate, but there was no significant difference when compared to those using autologous serum. The difference in defect area, degree of blepharospasm, and pericorneal injection was not statistically significant between the two treatment options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo-d-23-00023","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T05:41:44Z","timestamp":1694065304000},"page":"317-322","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Decreased levels of interleukin-6 level in tears and clinical changes in subjects with moderate-to-severe infection corneal ulcers treated with platelet-rich fibrin lysate eye drops"],"prefix":"10.4103","volume":"13","author":[{"given":"Jehan Fauzi","family":"Rakhmandani","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra Tri","family":"Mahayana","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Widyaputri","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reny","family":"Setyowati","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agus","family":"Supartoto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohanes Widodo","family":"Wirohadidjojo","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhardjo","family":"Pawiroranu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"R1-20240830","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"Resnikoff","year":"2004","journal-title":"Bull World Health Organ"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"443","DOI":"10.15850\/amj.v2n3.505","article-title":"Characteristics and predisposing factors of bacterial corneal ulcer in the National Eye Center, Cicendo Eye Hospital, Bandung from January to December 2011","volume":"2","author":"Putri","year":"2015","journal-title":"Althea Med J"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.87.7.834","article-title":"Bacterial keratitis:Predisposing factors, clinical and microbiological review of 300 cases","volume":"87","author":"Bourcier","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R4-20240830","first-page":"842","article-title":"Bacterial Keratitis infection:A battle between virulence factors and the immune response","volume":"85","author":"Robles-Contreras","year":"2013","journal-title":"Common Eye Infect"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.3390\/ijms16034850","article-title":"Expression of IL-8, IL-6 and IL-1b in tears as a main characteristic of the immune response in human microbial keratitis","volume":"16","author":"Santacruz","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1167\/iovs.11-7956","article-title":"Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing","volume":"52","author":"Ebihara","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20240830","first-page":"162","article-title":"Dry eye syndrome (sindroma mata kering)","volume":"20","author":"Asyari","year":"2007","journal-title":"Indones Dexa Media"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09273948.2016.1277247","article-title":"Roles of IL-6 in ocular inflammation:A review","volume":"26","author":"Ghasemi","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5935\/0034-7280.20170067","article-title":"The use of platelet rich-plasma in Ophthalmology:A literature review","volume":"76","author":"Ribeiro","year":"2017","journal-title":"Rev Bras Oftalmol"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1515\/med-2021-0259","article-title":"Platelet-rich fibrin:Basics of biological actions and protocol modifications","volume":"16","author":"Pavlovic","year":"2021","journal-title":"Open Med (Wars)"},{"key":"R11-20240830","first-page":"491","article-title":"Application of conjunctival hyperemia severity scale to assess color photographs of eyes with pterygia","volume":"61","author":"Bedolla","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/mdc3.13530","article-title":"Measurement properties of clinical scales rating the severity of blepharospasm:A multicenter observational study","volume":"9","author":"Defazio","year":"2022","journal-title":"Mov Disord Clin Pract"},{"key":"R13-20240830","first-page":"21","article-title":"Corneal ulcer:Diagnosis and management","volume":"12","author":"Garg","year":"1999","journal-title":"Community Eye Health"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ophtha.2006.10.044","article-title":"Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers","volume":"114","author":"Alio","year":"2007","journal-title":"Ophthalmology"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10384-012-0175-y","article-title":"Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis","volume":"56","author":"Kim","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3538764","article-title":"Clinical efficacy of platelet-rich plasma in the treatment of neurotrophic corneal ulcer","volume":"2018","author":"Wr\u00f3bel-Dudzi\u0144ska","year":"2018","journal-title":"J Ophthalmol"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3390\/diagnostics12092095","article-title":"Trends in infectious keratitis in Taiwan:An update on predisposing factors, microbiological and antibiotic susceptibility patterns","volume":"12","author":"Wang","year":"2022","journal-title":"Diagnostics (Basel)"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-23-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:12:42Z","timestamp":1787166762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-23-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-23-00023","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-02-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}